| TGF-β-induced quiescence mediates chemoresistance of tumor-propagating cells in squamous cell carcinoma JA Brown, Y Yonekubo, N Hanson, A Sastre-Perona, A Basin, ... Cell stem cell 21 (5), 650-664. e8, 2017 | 153 | 2017 |
| SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma JM Siegle, A Basin, A Sastre-Perona, Y Yonekubo, J Brown, R Sennett, ... Nature communications 5 (1), 4511, 2014 | 132 | 2014 |
| Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia K Oshima, J Zhao, P Pérez-Durán, JA Brown, JA Patiño-Galindo, T Chu, ... Nature Cancer 1 (11), 1113-1127, 2020 | 48 | 2020 |
| Runx2‐I is an Early Regulator of Epithelial–Mesenchymal Cell Transition in the Chick Embryo ALP Tavares, JA Brown, EC Ulrich, K Dvorak, RB Runyan Developmental Dynamics 247 (3), 542-554, 2018 | 33 | 2018 |
| CD44 promotes epithelial mammary gland development and exhibits altered localization during cancer progression JMV Louderbough, JA Brown, RB Nagle, JA Schroeder Genes & cancer 2 (8), 771-781, 2011 | 31 | 2011 |
| Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma JR Cortes, I Filip, R Albero, JA Patiño-Galindo, SA Quinn, WHW Lin, ... Cell reports 39 (3), 2022 | 19 | 2022 |
| The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma L Morgado-Palacin, JA Brown, TF Martinez, JM Garcia-Pedrero, ... Nature Communications 14 (1), 1328, 2023 | 18 | 2023 |
| Glucocorticoid resistance in acute lymphoblastic leukemia: BIM finally JA Brown, A Ferrando cancer cell 34 (6), 869-871, 2018 | 15 | 2018 |
| Cellular quiescence: how TGFβ protects cancer cells from chemotherapy JA Brown, M Schober Molecular & cellular oncology 5 (2), e1413495, 2018 | 7 | 2018 |
| Epigenetic reversal of hematopoietic stem cell aging in Phf6-knockout mice AA Wendorff, S Aidan Quinn, S Alvarez, JA Brown, M Biswas, T Gunning, ... Nature Aging 2 (11), 1008-1023, 2022 | 6 | 2022 |
| Joining forces: Bmi1 inhibition and cisplatin curb squamous carcinogenesis JA Brown, M Schober Cell Stem Cell 20 (5), 575-577, 2017 | 5 | 2017 |
| Modeling and countering the effects of cosmic radiation using bioengineered human tissues DN Tavakol, TR Nash, Y Kim, S He, S Fleischer, PL Graney, JA Brown, ... Biomaterials 301, 122267, 2023 | 4 | 2023 |
| m6A RNA modifications: Key regulators of normal and malignant hematopoiesis P Sommerkamp, JA Brown, MLR Haltalli, FE Mercier, LP Vu, KR Kranc Experimental Hematology 111, 25-31, 2022 | 2 | 2022 |
| 3018–BIOENGINEERED HUMAN MICROTISSUE MODEL OF HEALTHY AND LEUKEMIC BONE MARROW DN Tavakol, J Brown, P Graney, T Palomero, A Ferrando, ... Experimental Hematology 111, S53, 2022 | 1 | 2022 |
| 2020–BIOENGINEERED IPSC-DERIVED MODELS OF HUMAN BONE MARROW FOR STUDIES OF SYSTEMIC INJURY AND DISEASE D Tavakol, P Graney, I Baldassarri, S He, J Brown, A O'Donnell, ... Experimental Hematology 124, S46, 2023 | | 2023 |
| Defining a Quiescent Tumor Propagating Cell State in Squamous Cell Carcinoma J Brown New York University, 2018 | | 2018 |
| 131 Defining cellular quiescence as a multi-drug resistance mechanism in squamous cell carcinoma J Brown, Y Yonekubo, A Tsirigos Journal of Investigative Dermatology 137 (5), S22, 2017 | | 2017 |
